554 related articles for article (PubMed ID: 28207945)
1. CD4
Wei Y; Yu K; Wei H; Su X; Zhu R; Shi H; Sun H; Luo Q; Xu W; Xiao J; Zhong Y; Zeng Q
Immunology; 2017 Jul; 151(3):291-303. PubMed ID: 28207945
[TBL] [Abstract][Full Text] [Related]
2. Heme oxygenase-1 restores impaired GARPCD4⁺CD25⁺ regulatory T cells from patients with acute coronary syndrome by upregulating LAP and GARP expression on activated T lymphocytes.
Liu Y; Zhao X; Zhong Y; Meng K; Yu K; Shi H; Wu B; Tony H; Zhu J; Zhu R; Peng Y; Mao Y; Cheng P; Mao X; Zeng Q
Cell Physiol Biochem; 2015; 35(2):553-70. PubMed ID: 25612606
[TBL] [Abstract][Full Text] [Related]
3. Equine CD4(+) CD25(high) T cells exhibit regulatory activity by close contact and cytokine-dependent mechanisms in vitro.
Hamza E; Gerber V; Steinbach F; Marti E
Immunology; 2011 Nov; 134(3):292-304. PubMed ID: 21977999
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
5. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity in FoxP3- and GARP/LAP-Expressing T Regulatory Cells in an HLA Class II Transgenic Murine Model of Necrotizing Soft Tissue Infections by Group A Streptococcus.
Nookala S; Mukundan S; Fife A; Alagarsamy J; Kotb M
Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30224551
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
Luz-Crawford P; Kurte M; Bravo-Alegría J; Contreras R; Nova-Lamperti E; Tejedor G; Noël D; Jorgensen C; Figueroa F; Djouad F; Carrión F
Stem Cell Res Ther; 2013 Jun; 4(3):65. PubMed ID: 23734780
[TBL] [Abstract][Full Text] [Related]
8. Impairment of Circulating CD4⁺CD25⁺GARP⁺ regulatory T cells in patients with acute coronary syndrome.
Meng K; Zhang W; Zhong Y; Mao X; Lin Y; Huang Y; Lang M; Peng Y; Zhu Z; Liu Y; Zhao X; Yu K; Wu B; Ji Q; Zeng Q
Cell Physiol Biochem; 2014; 33(3):621-32. PubMed ID: 24603196
[TBL] [Abstract][Full Text] [Related]
9. Low responder T cell susceptibility to the suppressive function of regulatory T cells in patients with dilated cardiomyopathy.
Tang H; Zhong Y; Zhu Y; Zhao F; Cui X; Wang Z
Heart; 2010 May; 96(10):765-71. PubMed ID: 20448127
[TBL] [Abstract][Full Text] [Related]
10. Decreased suppression of CD8
Giri PS; Dwivedi M; Begum R
Exp Dermatol; 2020 Aug; 29(8):759-775. PubMed ID: 32682346
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
Cao Q; Wang L; Du F; Sheng H; Zhang Y; Wu J; Shen B; Shen T; Zhang J; Li D; Li N
Cell Res; 2007 Jul; 17(7):627-37. PubMed ID: 17563757
[TBL] [Abstract][Full Text] [Related]
12. Human retinal pigment epithelium-induced CD4+CD25+ regulatory T cells suppress activation of intraocular effector T cells.
Horie S; Sugita S; Futagami Y; Yamada Y; Mochizuki M
Clin Immunol; 2010 Jul; 136(1):83-95. PubMed ID: 20350837
[TBL] [Abstract][Full Text] [Related]
13. Loss of regulatory characteristics in CD4
Bian LQ; Mao L; Bi Y; Zhou SW; Chen ZD; Wen J; Shi J; Wang L
APMIS; 2017 Dec; 125(12):1108-1116. PubMed ID: 28913840
[TBL] [Abstract][Full Text] [Related]
14. Defective circulating CD4+LAP+ regulatory T cells in patients with dilated cardiomyopathy.
Zhu ZF; Tang TT; Dong WY; Li YY; Xia N; Zhang WC; Zhou SF; Yuan J; Liao MY; Li JJ; Jiao J; Nie SF; Wang Q; Tu X; Xu CQ; Liao YH; Shi GP; Cheng X
J Leukoc Biol; 2015 Apr; 97(4):797-805. PubMed ID: 25722319
[TBL] [Abstract][Full Text] [Related]
15. Expression of Th17 and CD4
Xiang M; Guo L; Ma Y; Li Y
Pak J Pharm Sci; 2016 Nov; 29(6 Suppl):2405-2410. PubMed ID: 28167485
[TBL] [Abstract][Full Text] [Related]
16. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
[TBL] [Abstract][Full Text] [Related]
17. [Effect of human bone marrow mesenchymal stem cells on allogeneic regulatory T cells and its possible mechanism].
Yang J; Wang QH; Zeng QT; Mao XB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):785-9. PubMed ID: 17708804
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulation of human CD19
Hong M; Liao Y; Liang J; Chen X; Li S; Liu W; Gao C; Zhong Z; Kong D; Deng J; Zhang J; Pan G
Hum Immunol; 2019 Oct; 80(10):863-870. PubMed ID: 31262519
[TBL] [Abstract][Full Text] [Related]
19. DC expressing transgene Foxp3 are regulatory APC.
Lipscomb MW; Taylor JL; Goldbach CJ; Watkins SC; Wesa AK; Storkus WJ
Eur J Immunol; 2010 Feb; 40(2):480-93. PubMed ID: 19941313
[TBL] [Abstract][Full Text] [Related]
20. Tumor Necrosis Factor-producing T-regulatory Cells Are Associated With Severe Liver Injury in Patients With Acute Hepatitis A.
Choi YS; Jung MK; Lee J; Choi SJ; Choi SH; Lee HW; Lee JJ; Kim HJ; Ahn SH; Lee DH; Kim W; Park SH; Huh JR; Kim HP; Park JY; Shin EC
Gastroenterology; 2018 Mar; 154(4):1047-1060. PubMed ID: 29229400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
